IMAGENT Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Imagent, and what generic alternatives are available?
Imagent is a drug marketed by Vesselon Spv Llc and Alliance Pharm and is included in two NDAs.
The generic ingredient in IMAGENT is perflubron. Additional details are available on the perflubron profile page.
Summary for IMAGENT
US Patents: | 0 |
Applicants: | 2 |
NDAs: | 2 |
Raw Ingredient (Bulk) Api Vendors: | 96 |
Patent Applications: | 5,295 |
Formulation / Manufacturing: | see details |
DailyMed Link: | IMAGENT at DailyMed |
US Patents and Regulatory Information for IMAGENT
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Vesselon Spv Llc | IMAGENT | dimyristoyl lecithin; perflexane | INJECTABLE;INTRAVENOUS | 021191-001 | May 31, 2002 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Alliance Pharm | IMAGENT | perflubron | LIQUID;ORAL | 020091-001 | Aug 13, 1993 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for IMAGENT
International Patents for IMAGENT
See the table below for patents covering IMAGENT around the world.
Country | Patent Number | Title | Estimated Expiration |
---|---|---|---|
Norway | 973489 | ⤷ Try a Trial | |
Australia | 731099 | ⤷ Try a Trial | |
Japan | 3559849 | ⤷ Try a Trial | |
Australia | 694135 | ⤷ Try a Trial | |
Hong Kong | 1013403 | ⤷ Try a Trial | |
Canada | 2164813 | COMPOSES DE MICRO-BULLES STABILISEES SERVANT D'AGENTS CONTRASTANTS (STABILIZED MICROBUBBLE COMPOSITIONS FOR ULTRASOUND) | ⤷ Try a Trial |
>Country | >Patent Number | >Title | >Estimated Expiration |